© Reuters.
Investing.com — U.S. stocks are mixed on Friday as tech tried to stage a comeback after earnings reports from Amazon and Intel.
Here are some of the biggest U.S. stock movers today:
-
Amazon (NASDAQ:) stock rose 7% after the e-commerce giant reported third-quarter results that topped expectations as growth in its cloud business continued to stabilize and advertising growth jumped.
-
Intel (NASDAQ:) stock rose 9.7% after the chip manufacturer delivered better-than-expected guidance for the current quarter after third-quarter earnings markedly beat analyst estimates amid signs PC demand has bottomed out.
-
Ford (NYSE:) stock fell more than 10% after the auto giant withdrew its full-year results forecast due to “uncertainty” over the pending ratification of its deal with the United Auto Workers union.
-
Exxon Mobil (NYSE:) stock fell 2.3% after the oil major posted a $9.1 billion third-quarter profit, an about 54% drop from record earnings a year ago but up from the prior quarter as oil prices recovered.
-
JPMorgan (NYSE:) stock fell 2.9% after the biggest U.S. bank said CEO Jamie Dimon would sell a portion of his stock holdings in the bank in 2024 for financial diversification and tax planning.
-
Chevron (NYSE:) stock fell 5.9% after the oil giant reported a fall in third-quarter profit despite higher oil prices, days after agreeing to buy smaller U.S. rival Hess (NYSE:) for $53 billion.
-
Natwest (NYSE:) stock fell 12.7% after the Financial Conduct Authority said it had identified potential “regulatory breaches” in the U.K.-based lender’s handling of a decision to close former Brexit party leader Nigel Farage’s accounts.
-
Sanofi (NASDAQ:) ADRs fell 19.5% after the French drugmaker dropped its 2025 profit target under a plan to list its consumer healthcare business, while lifting its development spending plans.
-
Enphase Energy (NASDAQ:) stock slumped 14% after the solar inverter maker missed quarterly revenue forecasts and offered full-year guidance well below expectations.
- AbbVie (NYSE:) stock fell 5.3% after the pharmaceutical company raised its annual profit forecast after beating quarterly earnings estimates, helped by a lower-than-feared drop in sales of its blockbuster arthritis drug, Humira, and strong demand for newer drugs.
- Colgate-Palmolive (NYSE:) stock fell 1.2% after the consumer goods company raised its annual organic sales and profit forecasts for a third time this year, betting on price hikes and steady demand for its self-care and pet nutrition products.
Read the full article here